Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Preliminary Evidence of a Link between COVID-19 Vaccines and Otologic Symptoms

View ORCID ProfileRamsi A. Woodcock, Loren J. Bartels
doi: https://doi.org/10.1101/2022.02.23.22271144
Ramsi A. Woodcock
1University of Kentucky Rosenberg College of Law, Secondary Appointment, Department of Management, University of Kentucky Gatton College of Business & Economics, Law Building, 620 S. Limestone, Lexington, KY 40506, United States of America
Roles: Assistant Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ramsi A. Woodcock
  • For correspondence: rwo236@uky.edu
Loren J. Bartels
2Tampa Bay Hearing and Balance Center, Clinical Professor of Otolaryngology, University of South Florida College of Medicine, 5 Tampa General Circle 610, Tampa, FL 33606, United States of America
Roles: Director
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Hypothesis This study investigates whether U.S. Centers for Disease Control and Prevention Vaccine Adverse Events Reporting System (VAERS) data suggest an association between vertigo, tinnitus, hearing loss, Bell’s palsy and the COVID-19 vaccines administered in the United States.

Background Published case reports suggest a possible association between various otologic symptoms and the COVID-19 vaccines, but the only published analysis of VAERS data, which did not account for underreporting of late-appearing adverse events, found no association between hearing loss and the vaccines.

Methods The incidence in VAERS of vertigo, tinnitus, hearing loss, and Bell’s palsy associated with COVID-19 vaccinations administered between December 14, 2020 and June 7, 2021 was compared with published rates for the general population. To account for underreporting of late-appearing adverse events, incidences were calculated using only the initial part of the observation period, during which reported events spike above expected events.

Results The COVID-19 vaccines were associated with statistically significant increases in the incidence of vertigo, tinnitus, hearing loss, and Bell’s palsy of 1877, 50, 12, and 14 cases per 100,000, respectively. In relation to the mRNA-1273 or BNT162b2 vaccines, the Ad26.COV2.S vaccine was associated with a statistically significant excess incidence of vertigo, tinnitus, and hearing loss of at least 723, 57, and 55 cases per 100,000, respectively.

Conclusion These results suggest an association between the COVID-19 vaccines and vertigo, tinnitus, hearing loss, and Bell’s palsy. They also suggest that, with respect to vertigo, tinnitus, and hearing loss, the association is relatively strong for the Ad26.COV2.S vaccine.

Competing Interest Statement

Ramsi A. Woodcock suffers from otologic symptoms that he believes to have been caused by COVID-19 vaccination. He is Loren J. Bartels' patient.

Funding Statement

This study did not receive any funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study uses data from the Vaccine Adverse Event Reporting System (VAERS) that is publicly available on the CDC website at https://wonder.cdc.gov/vaers.html.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Office Phone: +1-859-257-1253, Cell Phone (preferred): +1-646-385-3592, Email: rwo236{at}uky.edu

  • Office Phone: +1-813-315-4327, Email: lbartels{at}tampabayhearing.com

  • Sources of Support/Disclosure of Funding: This study received no outside support or funding.

  • Conflicts of Interest: Ramsi A. Woodcock suffers from otologic symptoms that he believes to have been caused by COVID-19 vaccination. He is Loren J. Bartels’ patient.

Data Availability

No data were produced for the study. All data analyzed in this study were downloaded from https://wonder.cdc.gov/vaers.html. All data and calculations used in the study can be downloaded in Excel format from this link: https://www.dropbox.com/s/82m4h7cba9g6h4v/TinnitusHearingLossVAERS%205.xlsx?dl=0

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 24, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Preliminary Evidence of a Link between COVID-19 Vaccines and Otologic Symptoms
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Preliminary Evidence of a Link between COVID-19 Vaccines and Otologic Symptoms
Ramsi A. Woodcock, Loren J. Bartels
medRxiv 2022.02.23.22271144; doi: https://doi.org/10.1101/2022.02.23.22271144
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Preliminary Evidence of a Link between COVID-19 Vaccines and Otologic Symptoms
Ramsi A. Woodcock, Loren J. Bartels
medRxiv 2022.02.23.22271144; doi: https://doi.org/10.1101/2022.02.23.22271144

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Otolaryngology
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1244)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (532)
  • Epidemiology (10027)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2462)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1645)
  • Health Policy (753)
  • Health Systems and Quality Improvement (636)
  • Hematology (250)
  • HIV/AIDS (535)
  • Infectious Diseases (except HIV/AIDS) (11871)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (253)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2289)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1248)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (733)
  • Pharmacology and Therapeutics (314)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4840)
  • Radiology and Imaging (838)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (651)
  • Rheumatology (286)
  • Sexual and Reproductive Health (240)
  • Sports Medicine (227)
  • Surgery (268)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)